Developmental progress of CRISPR/Cas9 and its therapeutic applications for HIV-1 infection

被引：8
|
作者：
Deng, Qiudi [1 ]
Chen, Zisheng [2 ]
Shi, Lei [3 ]
Lin, Huafeng [1 ,3 ]
机构：
[1] Jinan Univ, Coll Life Sci & Technol, Dept Biotechnol, Guangzhou 510632, Guangdong, Peoples R China
[2] Guangzhou Med Univ, Affiliated Hosp 6, Dept Resp Med, Qingyuan, Peoples R China
[3] Jinan Univ, Dept Food Safety & Nutr Res, Guangzhou, Guangdong, Peoples R China
来源：
REVIEWS IN MEDICAL VIROLOGY | 2018年 / 28卷 / 05期
关键词：
CCR5; CRISPR/Cas9; gene editing; HIV-1; infection; RNA-GUIDED ENDONUCLEASE; ZINC-FINGER-NUCLEASES; HUMAN T-CELLS; LATENT HIV-1; CRYSTAL-STRUCTURE; PROVIRAL DNA; VIRAL ESCAPE; CAS SYSTEMS; GENE; GENOME;
D O I：
10.1002/rmv.1998
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
The CRISPR/Cas9 system has been developed as a powerful tool for targeted gene editing. As a result of technical enhancements in recent years, this technology has become the method of choice for efficiently modifying targeted HIV-1 genome efficiently as part of HIV therapy. CRISPR can be modified to target specific sequences that Cas9 then cuts. In this article, we outline the development of the CRISPR/Cas9 system. We also show how this technology can be used for the prevention and treatment of HIV-1 infection. Optimistically, this technology promises to make a significant impact on the fight against HIV-1 in the future.
引用
收藏
页数：7
相关论文
共 50 条
  • [1] CRISPR/Cas9 Inhibits Multiple Steps of HIV-1 Infection
    Yin, Lijuan
    Hu, Siqi
    Mei, Shan
    Sun, Hong
    Xu, Fengwen
    Li, Jian
    Zhu, Weijun
    Liu, Xiaoman
    Zhao, Fei
    Zhang, Di
    Cen, Shan
    Liang, Chen
    Guo, Fei
    [J]. HUMAN GENE THERAPY, 2018, 29 (11) : 1264 - 1276
  • [2] CRISPR/Cas9 inhibits multiple steps of HIV-1 infection
    Yin, L.
    Hu, S.
    Mei, S.
    Sun, H.
    Xu, F.
    Li, J.
    Zhu, W.
    Liu, X.
    Zhao, F.
    Zhang, D.
    Cen, S.
    Liang, C.
    Guo, F.
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1075 - 1075
  • [3] CRISPR/Cas9: a tool to eradicate HIV-1
    Ruchira Bhowmik
    Binay Chaubey
    [J]. AIDS Research and Therapy, 19
  • [4] CRISPR/Cas9: a tool to eradicate HIV-1
    Bhowmik, Ruchira
    Chaubey, Binay
    [J]. AIDS RESEARCH AND THERAPY, 2022, 19 (01)
  • [5] CRISPR–Cas9 defence against HIV-1
    Cláudio Nunes-Alves
    [J]. Nature Reviews Microbiology, 2015, 13 (5) : 250 - 250
  • [6] Applications of CRISPR/Cas9 tools in deciphering the mechanisms of HIV-1 persistence
    Verdikt, Roxane
    Darcis, Gilles
    Ait-Ammar, Amina
    Van Lint, Carine
    [J]. CURRENT OPINION IN VIROLOGY, 2019, 38 : 63 - 69
  • [7] The therapeutic application of CRISPR/Cas9 technologies for HIV
    Saayman, Sheena
    Ali, Stuart A.
    Morris, Kevin V.
    Weinberg, Marc S.
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (06) : 819 - 830
  • [8] Selection of gRNAs to target the HIV-1 quasispecies with CRISPR/cas9
    Dampier, W.
    Nonnemacher, M.
    Chung, C-H
    Allen, A.
    Sullivan, N.
    Desimone, M.
    Pirrone, V
    Kercher, K.
    Passic, S.
    Williams, J.
    Wigdahl
    [J]. JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2017, 12 : S52 - S53
  • [9] Selection of gRNAs to target the HIV-1 quasispecies with CRISPR/cas9
    Allen, Alexander
    Nonnemacher, Michael
    Dampier, William
    Desimone, Matthew
    Pirrone, Vanessa
    Kercher, Katie
    Passic, Shendra
    Williams, Jean
    Wigdahl, Brian
    [J]. JOURNAL OF NEUROVIROLOGY, 2016, 22 : S2 - S3
  • [10] Use of the CRISPR/Cas9 system as an intracellular defense against HIV-1 infection in human cells
    Hsin-Kai Liao
    Ying Gu
    Arturo Diaz
    John Marlett
    Yuta Takahashi
    Mo Li
    Keiichiro Suzuki
    Ruo Xu
    Tomoaki Hishida
    Chan-Jung Chang
    Concepcion Rodriguez Esteban
    John Young
    Juan Carlos Izpisua Belmonte
    [J]. Nature Communications, 6
12345